Oral Zinc Gluconate as Treatment for Recalcitrant Cutaneous Warts: A Randomized, Double-blind, Placebo-controlled Trial

Exclusion Criteria

• •1. Current or history of mental illness
• •2. Current or history of malignancy
• •3. Severe immunodeficiency states
• •4. Pregnant or lactating
• •5. Documented adverse effects to oral or topical zinc exposure
• •6. Oral intake of zinc supplements in the past 12 months or less
• •7. Oral Intake of H2 antagonists in the past 4 weeks or less
• •8. Oral intake of immunosuppressives in the past 4 weeks or less
• •9. Concurrent usage of other treatment modalities
• •10. Current anogenital warts